October 29th 2024
Are SDOHs associated with Medicare, Medicaid, and private insurer spending?
October 24th 2024
How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
October 22nd 2024
The offering will become available in 49 states by next year.
October 18th 2024
A panel dives into the current and future outlook of healthcare policies.
October 17th 2024
Session dives into how healthcare policy implementation impacts stakeholders long-term.
AGC Biologics begins construction of new facility in Denmark
Venture anticipated to more than double single-use bioreactor mammalian cell-culture capacity on site
AmerisourceBergen expands manufacturer rolodex, purchases FirstView Financial
Acquisition addresses the need for meeting healthcare sector’s patient support demand
Recro lands IRISYS in CDMO acquisition
Deal allows for bicoastal expansion of pharmaceutical services
Effective patient-first approach in rare disease relies on true sales—not channel stocking
How the development of more quantitative and qualitative data around the patient can drive better-informed care decisions—and help avoid potential overstock scenarios that can deplete earnings
Biden highlights drug pricing reforms to advance legislative agenda
Plan aims to offset costs associated with proposed social and health initiatives
BeiGene to build new manufacturing and R&D center in the Garden State
Among focal points, New Jersey location will support clinical research, pharmacovigilance
BMS finalizes sale of European facility
WuXi STA will take reigns of the operations, as CDMO expands
Where will the next life sciences business cluster grow?
State and regional economic-development authorities compete fiercely for siting new pharma enterprises, and holding onto the ones they have. But pharma’s stupendous growth in investment is giving all regions a boost
Report: Cell and gene therapy market to reach $57.4 billion by 2028
Sector is expected to be driven by a rise in drug development and regulatory approvals for advanced therapies
Sanofi bets big on mRNA, inks $3.2B deal for Translate Bio
Acquisition of US partner establishes Sanofi's plan to advance messenger RNA technology for vaccines, therapeutics
GS1 US releases new guideline for sharing product data
Guidance supports cross-industry collaboration for improved interoperability
Report: PE firms are purchasing CMOs at a swift clip
Private equity companies see the sector as having a valuable ROI, according to study
InSourceRx partners with MDsave in patient access arrangement
Pharmacy discount card company and e-commerce specialist team up on new Rx-med procedures channel
PerkinElmer to acquire BioLegend for $5.25 billion
Deal for antibody developer expected to be largest ever for scientific instrument maker
Eversana expands North American reach, pens deal for Accelera Canada
Acquisition is centered on market access and patient advocacy
Survey: Pharma partnerships valued in harnessing 'smart' tech
Report notes that companies particularly look to vendor support for technologies such as 5G, IoT, and blockchain
Catalent to further grow its Italian biologics facility
Plans a multi-phase, $100 million expansion, adding biologics drug substance manufacturing capabilities
Partners Group agrees to purchase Pharmathen for $1.89 billion
Deal allows CDMO to quickly expand its drug delivery technologies in the US
Medable opens EMEA headquarters in Ireland
Aims to grow its digital clinical trial offerings internationally
Ardena boosts investment in its European sites
CDMO looks to strengthen its presence in Belgium, Sweden and the Netherlands
Ashfield creates cell and gene therapy commercialization network
EmerGENE to support biotechs in clinical-to-commercialization process, including distribution and logistics
Craneware completes purchase of healthcare IT firms Sentry, Agilum
Bundled $400 million acquisition provides data insights to hospitals, retail pharmacies
United States Pharmacopeia inks deal for life science consultancy
Acquisition by nonprofit will focus on helping strengthen drug supply chain
Celularity and Arthrex ink exclusive commercial supply and distribution pact
Arthrex to receive US rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sports medicine
Accenture strengthens its cyber defense efforts in Sweden
Acquires Sweden-based Sentor, which specializes in security services
UBC forms patient support partnership
Collaboration with Surescripts will focus on improving patient outcomes, while providing HCPs with in-workflow enrollment
Sanofi invests in mRNA Center of Excellence for vaccines
Mission is to expand its collection of mRNA vaccines beyond the Covid-19 pandemic
New company formed focused on pharma patient portal, drug adherence
Merger establishes Perigon Health 360—with aim of introducing "precision digital pharmacy" model
French company Novasep pursues API facility upgrade
Mourenx location will install new equipment, add hires in project as part of the France Relance recovery plan
Annual list of top 50 pharma companies released
Roche repeats at No. 1 position; AbbVie vaults five spots